Clinically, increased FAK expression is associated with worse prognosis in lung [29] and colon cancer [30], and FAK-copy-gain is one of the mechanisms of FAK overexpression in breast and gastric cancers [15,31]. Here, PTK2 is linked to gastric cancer.